Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and Proliferation Assay Using WST-8

Executive Summary: The Cell Counting Kit-8 (CCK-8) by APExBIO is a colorimetric assay for quantifying cell viability, proliferation, and cytotoxicity using water-soluble WST-8 tetrazolium salt. CCK-8 enables rapid and sensitive detection of mitochondrial dehydrogenase activity in live cells, correlating absorbance directly with viable cell number (APExBIO CCK-8). The assay is more sensitive and user-friendly than MTT/XTT/MTS or WST-1 methods, requiring no solubilization step (see comparative analysis). CCK-8 is widely used in cancer research, drug screening, and studies of cellular metabolic activity, including assessment of ferroptosis and cytotoxicity (Zhou et al., 2024). The water-soluble formazan dye generated allows direct absorbance measurement, streamlining workflows and boosting reproducibility.

Biological Rationale

Cell viability and proliferation assays are central to cell biology, oncology, and pharmacology research. Accurate quantification of living cells enables assessment of drug cytotoxicity, proliferation rates, and metabolic activity. Traditional methods such as MTT, XTT, and MTS rely on tetrazolium salts but require solubilization of formazan crystals, adding workflow complexity. The Cell Counting Kit-8 (CCK-8) utilizes WST-8, a water-soluble tetrazolium salt, to simplify and improve the reliability of cell viability detection (APExBIO, product page). WST-8 is reduced by cellular dehydrogenases in metabolically active cells, generating a soluble formazan dye measurable at 450 nm. This approach directly correlates absorbance with cell number and viability. The utility of CCK-8 extends to diverse applications including cancer research, neurodegenerative disease modeling, and cytotoxicity screening (application overview).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The CCK-8 assay employs WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt), a water-soluble tetrazolium salt. In viable eukaryotic cells, WST-8 is enzymatically reduced by mitochondrial dehydrogenases to yield an orange water-soluble formazan product. This reduction is dependent on intracellular NADH/NADPH, which is produced by active cellular metabolism (Zhou et al., 2024). The amount of formazan dye generated is directly proportional to the number of live cells present. The main advantages of WST-8 over MTT or WST-1 are its higher sensitivity, linear correlation with cell number, and elimination of the solubilization step. The formazan product is stable and can be measured at 450 nm using a standard microplate reader. The reaction is non-toxic, allowing subsequent downstream assays on the same cells.

Evidence & Benchmarks

• CCK-8 enables sensitive detection of cell viability and proliferation with a linear response in the range of 500–50,000 cells/well (96-well format) (APExBIO, product page).
• WST-8 based assays exhibit higher sensitivity and lower background compared to traditional MTT/XTT/MTS or WST-1 methods (comparative review).
• CCK-8 has been validated for quantifying cytotoxicity and metabolic inhibition induced by small molecules, such as verteporfin in pancreatic cancer cells (Zhou et al., 2024, Table 1).
• In Zhou et al. (2024), CCK-8 was used to demonstrate that verteporfin treatment causes rapid loss of cell viability in PDAC cell lines, with effects confirmed by parallel ROS and lipid peroxidation assays (Zhou et al., 2024, Figure 2B).
• CCK-8 is compatible with high-throughput workflows and can be adapted to 384-well formats for drug screening (workflow extension).

For a contrast with deeper workflow optimization, see 'Maximizing Cell Assay Reliability' (this article provides new evidence on sensitivity and mechanistic specificity in cancer drug testing).

Applications, Limits & Misconceptions

CCK-8 is widely applied in the following domains:

• Cancer research: Quantifying cytotoxic and anti-proliferative effects of chemotherapeutics (Zhou et al., 2024).
• Neurodegenerative disease studies: Assessing neuronal viability and metabolic integrity (applications overview).
• Cellular metabolic activity assessment: Monitoring mitochondrial dehydrogenase activity as a surrogate for cell health.
• Drug screening: High-throughput evaluation of compound libraries for cytotoxicity or proliferation impact (see strategic insights—this article updates with direct benchmarking against newer photodynamic drugs).

Common Pitfalls or Misconceptions

• CCK-8 does not distinguish between cell death modalities: The assay measures loss of metabolic activity, but cannot differentiate apoptosis, necrosis, or ferroptosis without additional markers (Zhou et al., 2024).
• Some compounds may interfere with WST-8 reduction: Redox-active drugs or high antioxidant concentrations can yield false positives or negatives; controls are essential.
• Confluence and plating density affect linearity: Exceeding optimal seeding ranges can saturate absorbance readings and reduce assay accuracy (comparative review).
• Not suitable for non-metabolically active cells: Dormant or fixed cells will not reduce WST-8, leading to underestimation of cell presence.
• Incubation time must be optimized per cell type: Different cell lines metabolize WST-8 at variable rates; pilot experiments are recommended.

Workflow Integration & Parameters

The CCK-8 assay is designed for ease of use. After seeding cells (typically 500–10,000/well in 96-well plates), 10 μL of the CCK-8 reagent is added to each well containing 100 μL of culture medium. Plates are incubated at 37°C (5% CO₂) for 1–4 hours, depending on cell type and density. Absorbance is measured at 450 nm using a microplate reader. No solubilization is required, and the water-soluble formazan product allows for direct quantification (Cell Counting Kit-8 (CCK-8), APExBIO). The protocol is scalable to 24-, 48-, or 384-well formats. CCK-8 is non-toxic, so parallel assays (e.g., fluorescence staining, gene expression) can be performed on the same cells. For detailed mechanistic integration and translational research strategies, see 'Translational Precision'—this article extends the discussion by providing specific benchmarks and troubleshooting guidance.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8, SKU K1018) from APExBIO represents a robust, sensitive, and high-throughput solution for quantifying cell viability, proliferation, and cytotoxicity. Its WST-8 chemistry offers improved linearity, reduced background, and streamlined workflow compared to older MTT/XTT/MTS assays. CCK-8 has become a standard tool in cancer research and drug screening, supporting reproducible and scalable biomedical discovery. Future applications may include integration with multiplexed readouts or live-cell imaging. For comprehensive protocol details and ordering information, visit the Cell Counting Kit-8 (CCK-8) product page.